Veterinary Pharmacovigilance Global Market Report 2025

Description

Veterinary pharmacovigilance is the field focused on detecting, assessing, understanding, and preventing adverse effects or other drug-related issues in animals. It involves monitoring and evaluating the safety and efficacy of veterinary medicines after their approval. The aim is to ensure that the benefits of these medicines outweigh the risks, thus promoting animal health and welfare while also protecting human health and the environment.

The main types of veterinary pharmacovigilance are in-house and outsourced. In-house pharmacovigilance involves the monitoring and assessment of adverse drug reactions and safety-related data conducted by the pharmaceutical or veterinary company itself. This includes the use of software and services for products such as biologics and anti-infectives. The scope covers various animal types, including companion animals, livestock, and others. End users of these services include veterinary hospitals, veterinary companies, and academic and research institutes.

The veterinary pharmacovigilance market research report is one of a series of new reports from the business research company that provides veterinary pharmacovigilance market statistics, including veterinary pharmacovigilance industry global market size, regional shares, competitors with an veterinary pharmacovigilance market share, detailed veterinary pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmacovigilance industry. This veterinary pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmacovigilance market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing awareness of animal health, growth in the companion animal population, rising demand for livestock products, expanding veterinary services, and higher prevalence of zoonotic diseases.

The veterinary pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $1.5 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing pet ownership and spending, rising veterinary expenditure, growing focus on animal welfare, expansion of telemedicine in veterinary services, and higher demand for personalized veterinary care. Major trends in the forecast period include adoption of digital reporting systems, expansion of telehealth services for veterinary care, integration of blockchain for data security, and development of cloud-based pharmacovigilance platforms.

The increasing demand for animal health and medicinal products is projected to drive the growth of the veterinary pharmacovigilance market. Animal health and medicine products include food, medications, and grooming items designed to support the health and well-being of pets. This growing demand is fueled by rising pet ownership, advances in veterinary medicine, and the need to boost livestock productivity. Moreover, greater awareness of animal welfare and a higher incidence of animal diseases are contributing to this surge. Veterinary pharmacovigilance plays a crucial role in pet care by ensuring the safety and effectiveness of medications through monitoring and assessing adverse effects and ensuring regulatory compliance. For example, the Republic of Estonia's Agency of Medicines (Ravimiamet) reported in March 2024 that the veterinary medicinal products sector grew by 6.9% in 2023, reaching 18.6 million euros, compared to 17.4 million euros in 2022. This growth in demand for animal health and medicinal products is expected to drive the veterinary pharmacovigilance market.

Key companies in the veterinary pharmacovigilance sector are concentrating on enhancing regulatory frameworks through developments in data analytics, such as adverse event reporting (REAS) and safety report preparation. These processes involve documenting and analyzing harmful reactions to veterinary drugs to assess safety and ensure compliance with regulatory standards. For instance, in August 2024, Mexico's Ministry of Agriculture and Rural Development launched a new veterinary pharmacovigilance system. Developed by SENASICA, this system aims to ensure the safety, quality, and efficacy of veterinary drugs in Mexico. It gathers data on adverse reactions from various stakeholders, including pharmaceutical companies, distributors, veterinary hospitals, and veterinarians, to identify, assess, and mitigate risks associated with these medications. The system includes the veterinary pharmacovigilance guide (REAS) for documenting adverse reactions and monitoring issues such as efficacy, residue limits, and environmental impacts.

In January 2024, Veterinary Pharmaceutical Solutions, a US-based company specializing in veterinary services, acquired Diamond Animal Health, Inc. for an undisclosed amount. This acquisition is intended to expand Veterinary Pharmaceutical Solutions' product range, enhance its research and development capabilities, and improve operational efficiencies within the animal health industry. Diamond Animal Health Inc. is a US-based contract manufacturing and research firm offering regulatory affairs consulting, a component of veterinary pharmacovigilance services.

Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group

North America was the largest region in the veterinary pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary pharmacovigilance market consists of revenues earned by entities by providing services such as monitoring adverse drug reactions, assessing medication safety, collecting and analyzing safety data, conducting risk management, and ensuring regulatory compliance for veterinary medicines. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary pharmacovigilance market also includes sales of databases, reporting systems, safety assessment tools, and monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmacovigilance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: In House; Outsourced
2) By Solution: Software; Services
3) By Product: Biologics; Anti Infectives; Other Products
4) By Animal Type: Companion Animals; Livestock Animals; Other Animal Types
5) By End User: Veterinary Hospitals; Veterinary Companies; Academic And Research Institutes
Subsegments:
1) By In House: Internal Pharmacovigilance Departments; In-House Monitoring And Reporting Systems; Veterinary Adverse Event Management Software
2) By Outsourced: Third-Party Pharmacovigilance Services; Contract Research Organizations (CROs) For Pharmacovigilance; Pharmacovigilance Consulting And Support Services
Companies Mentioned: Accenture PLC; Zoetis Inc; Boehringer Ingelheim Animal Health; Elanco Animal Health Incorporated; Covetrus Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33932

1. Executive Summary

2. Veterinary Pharmacovigilance Market Characteristics

3. Veterinary Pharmacovigilance Market Trends And Strategies

4. Veterinary Pharmacovigilance Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Pharmacovigilance Growth Analysis And Strategic Analysis Framework

5.1. Global Veterinary Pharmacovigilance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Veterinary Pharmacovigilance Market Growth Rate Analysis
5.4. Global Veterinary Pharmacovigilance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Veterinary Pharmacovigilance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Veterinary Pharmacovigilance Total Addressable Market (TAM)

6. Veterinary Pharmacovigilance Market Segmentation

6.1. Global Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In House
Outsourced
6.2. Global Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.3. Global Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Anti Infectives
Other Products
6.4. Global Veterinary Pharmacovigilance Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Companion Animals
Livestock Animals
Other Animal Types
6.5. Global Veterinary Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Veterinary Companies
Academic And Research Institutes
6.6. Global Veterinary Pharmacovigilance Market, Sub-Segmentation Of In House, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Internal Pharmacovigilance Departments
In-House Monitoring And Reporting Systems
Veterinary Adverse Event Management Software
6.7. Global Veterinary Pharmacovigilance Market, Sub-Segmentation Of Outsourced, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Third-Party Pharmacovigilance Services
Contract Research Organizations (CROs) For Pharmacovigilance
Pharmacovigilance Consulting And Support Services

7. Veterinary Pharmacovigilance Market Regional And Country Analysis

7.1. Global Veterinary Pharmacovigilance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Veterinary Pharmacovigilance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Pharmacovigilance Market

8.1. Asia-Pacific Veterinary Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Pharmacovigilance Market

9.1. China Veterinary Pharmacovigilance Market Overview
9.2. China Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Pharmacovigilance Market

10.1. India Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Pharmacovigilance Market

11.1. Japan Veterinary Pharmacovigilance Market Overview
11.2. Japan Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Pharmacovigilance Market

12.1. Australia Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Pharmacovigilance Market

13.1. Indonesia Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Pharmacovigilance Market

14.1. South Korea Veterinary Pharmacovigilance Market Overview
14.2. South Korea Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Pharmacovigilance Market

15.1. Western Europe Veterinary Pharmacovigilance Market Overview
15.2. Western Europe Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Pharmacovigilance Market

16.1. UK Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Pharmacovigilance Market

17.1. Germany Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Pharmacovigilance Market

18.1. France Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Pharmacovigilance Market

19.1. Italy Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Pharmacovigilance Market

20.1. Spain Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Pharmacovigilance Market

21.1. Eastern Europe Veterinary Pharmacovigilance Market Overview
21.2. Eastern Europe Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Pharmacovigilance Market

22.1. Russia Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Pharmacovigilance Market

23.1. North America Veterinary Pharmacovigilance Market Overview
23.2. North America Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Pharmacovigilance Market

24.1. USA Veterinary Pharmacovigilance Market Overview
24.2. USA Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Pharmacovigilance Market

25.1. Canada Veterinary Pharmacovigilance Market Overview
25.2. Canada Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Pharmacovigilance Market

26.1. South America Veterinary Pharmacovigilance Market Overview
26.2. South America Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Pharmacovigilance Market

27.1. Brazil Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Pharmacovigilance Market

28.1. Middle East Veterinary Pharmacovigilance Market Overview
28.2. Middle East Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Pharmacovigilance Market

29.1. Africa Veterinary Pharmacovigilance Market Overview
29.2. Africa Veterinary Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Veterinary Pharmacovigilance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Veterinary Pharmacovigilance Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Pharmacovigilance Market Competitive Landscape And Company Profiles

30.1. Veterinary Pharmacovigilance Market Competitive Landscape
30.2. Veterinary Pharmacovigilance Market Company Profiles
- 30.2.1. Accenture PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Covetrus Inc Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Pharmacovigilance Market Other Major And Innovative Companies

31.1. IDEXX Laboratories, Inc.
31.2. Ceva Sante Animale
31.3. Virbac SA
31.4. Merck Animal Health
31.5. Huvepharma EOOD
31.6. Norbrook Laboratories Ltd
31.7. ProPharma Group
31.8. ArisGlobal LLC
31.9. PQE Group
31.10. Chanelle Pharma Group Ltd
31.11. Clinvet International
31.12. Ennov SAS
31.13. Sarjen Systems Pvt. Ltd
31.14. PharSafer Associates Ltd
31.15. Medfiles Oy

32. Global Veterinary Pharmacovigilance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Pharmacovigilance Market

34. Recent Developments In The Veterinary Pharmacovigilance Market

35. Veterinary Pharmacovigilance Market High Potential Countries, Segments and Strategies

35.1 Veterinary Pharmacovigilance Market In 2029 - Countries Offering Most New Opportunities
35.2 Veterinary Pharmacovigilance Market In 2029 - Segments Offering Most New Opportunities
35.3 Veterinary Pharmacovigilance Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer